Charles H. Randall's most recent trade in SAB Biotherapeutics Inc was a trade of 145,681 Earnout Rights (Restricted Stock Units) done . Disclosure was reported to the exchange on Oct. 22, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
SAB Biotherapeutics Inc | Charles H. Randall | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2021 | 145,681 | 145,681 | - | - | Earnout Rights (Restricted Stock Units) | |
SAB Biotherapeutics Inc | Charles H. Randall | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2021 | 116,321 | 116,321 | - | - | Employee Stock Option (right to buy) | |
SAB Biotherapeutics Inc | Charles H. Randall | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2021 | 116,321 | 116,321 | - | - | Employee Stock Option (right to buy) | |
SAB Biotherapeutics Inc | Charles H. Randall | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2021 | 116,321 | 116,321 | - | - | Employee Stock Option (right to buy) | |
SAB Biotherapeutics Inc | Charles H. Randall | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2021 | 11,632 | 11,632 | - | - | Employee Stock Option (right to buy) |